A detailed history of American Century Companies Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 273,449 shares of VKTX stock, worth $19.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
273,449
Previous 832,132 67.14%
Holding current value
$19.9 Million
Previous $68.2 Million 78.76%
% of portfolio
0.01%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$47.39 - $80.2 $26.5 Million - $44.8 Million
-558,683 Reduced 67.14%
273,449 $14.5 Million
Q1 2024

May 14, 2024

SELL
$17.4 - $94.5 $24.2 Million - $132 Million
-1,391,690 Reduced 62.58%
832,132 $68.2 Million
Q4 2023

Feb 13, 2024

BUY
$9.24 - $19.64 $20.5 Million - $43.7 Million
2,223,822 New
2,223,822 $41.4 Million
Q3 2023

Nov 13, 2023

BUY
$10.92 - $16.0 $8.98 Million - $13.2 Million
822,156 Added 59.57%
2,202,228 $24.4 Million
Q2 2023

Aug 14, 2023

BUY
$14.84 - $24.79 $20.1 Million - $33.6 Million
1,355,183 Added 5444.91%
1,380,072 $22.4 Million
Q1 2023

May 11, 2023

BUY
$8.08 - $17.33 $44,795 - $96,077
5,544 Added 28.66%
24,889 $414,000
Q4 2022

Feb 13, 2023

BUY
$2.72 - $9.4 $52,618 - $181,843
19,345 New
19,345 $181,000
Q1 2020

May 14, 2020

SELL
$3.45 - $7.95 $1.98 Million - $4.57 Million
-574,424 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$6.38 - $8.73 $1.66 Million - $2.28 Million
260,768 Added 83.14%
574,424 $4.61 Million
Q3 2019

Nov 13, 2019

BUY
$6.55 - $8.6 $123,912 - $162,694
18,918 Added 6.42%
313,656 $2.16 Million
Q2 2019

Aug 14, 2019

BUY
$7.67 - $10.63 $439,276 - $608,801
57,272 Added 24.12%
294,738 $2.45 Million
Q1 2019

May 14, 2019

SELL
$7.58 - $9.94 $81,485 - $106,855
-10,750 Reduced 4.33%
237,466 $0
Q4 2018

Feb 13, 2019

SELL
$7.16 - $16.21 $41,191 - $93,256
-5,753 Reduced 2.27%
248,216 $1.9 Million
Q3 2018

Nov 02, 2018

BUY
$9.7 - $19.65 $2.46 Million - $4.99 Million
253,969 New
253,969 $4.42 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.59B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.